Inventor · disambiguated record
Matthias Birtel
Also filed as: BIRTEL MATTHIAS
1 granted patent·5 pending applications·2 citations·filing 2016–2022
18Inventor score
Files withBIONTECH CELL & GENE THERAPIES GMBH6
Top patents by PatentIndex Score
6 records- 0174US11702631B2Antigen receptors and uses thereofBIONTECH CELL & GENE THERAPIES GMBH·Filed 2018·Granted Jul 18, 2023·2 cites·15 claims
- 0270US2023119334A1Antigen receptors and uses thereofBIONTECH CELL & GENE THERAPIES GMBH·Filed 2022·Application pending·0 cites
- 0366US2022033461A1Antigen receptors and uses thereofBIONTECH CELL & GENE THERAPIES GMBH·Filed 2021·Application pending·0 cites
- 0451US2025339533A1Agents and methods for activation and targeting of immune effector cellsBIONTECH CELL & GENE THERAPIES GMBH·Filed 2022·Application pending·0 cites
- 0548US2023000962A1Treatment involving immune effector cells genetically modified to express antigen receptorsBIONTECH CELL & GENE THERAPIES GMBH·Filed 2020·Application pending·0 cites
- 0648US2018282390A1Antigen receptors and uses thereofBIONTECH CELL & GENE THERAPIES GMBH·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthias Birtel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →